Goldman Sachs’s InflaRx IFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-107,674
Closed -$459K 5580
2020
Q3
$459K Sell
107,674
-3,949
-4% -$18.2K ﹤0.01% 4521
2020
Q2
$512K Sell
111,623
-34,279
-23% -$222K ﹤0.01% 4368
2020
Q1
$557K Sell
145,902
-20,000
-12% -$74.1K ﹤0.01% 4149
2019
Q4
$657K Sell
165,902
-50,000
-23% -$146K ﹤0.01% 4351
2019
Q3
$533K Sell
215,902
-8,745
-4% -$25.4K ﹤0.01% 4415
2019
Q2
$710K Buy
224,647
+106,074
+89% +$3.36M ﹤0.01% 4206
2019
Q1
$4.48M Buy
+118,573
New +$4.42M ﹤0.01% 3056

Other funds holding IFRX

Goldman Sachs's IFRX Position: Q4 2020 in Review

Goldman Sachs sold out of InflaRx (IFRX) in Q4 2020, closing a stake of 107,674 shares — an estimated $459K sold.

Goldman Sachs first reported a position in IFRX in Q1 2019 and held it in 7 quarters. The position peaked at $4.48M in Q1 2019. 33 funds tracked by Wall St. Rank hold IFRX as of Q4 2020.

  • Goldman Sachs reported no remaining InflaRx position as of Q4 2020 after selling out during the quarter.
  • Goldman Sachs sold 107,674 InflaRx shares in Q4 2020, an estimated $459K.
  • Goldman Sachs first reported a position in InflaRx in Q1 2019 and held it in 7 quarters.
  • Goldman Sachs's InflaRx position peaked at $4.48M in Q1 2019.
  • 33 funds tracked by Wall St. Rank held InflaRx as of Q4 2020.

Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.